Stephen Hoag

UMSOP and KamTek Collaborate on Therapeutic Development to Treat Deadly Infections

November 23, 2020

Award from the Maryland Industrial Partnerships (MIPS) program supports work to formulate Clofazimine for treatment of recurrent C. difficile infections.

M-CERSI Workshop Explores Advances, Challenges in Pediatric Drug Development

September 9, 2019

More than 100 researchers from academia, government, and industry come together to share existing knowledge, new approaches, best practices, and continued challenges in pediatric drug formulation.

School of Pharmacy Joins National Institute for Biopharmaceuticals Manufacturing

January 18, 2017

Multimillion-dollar initiative will help bring safe biopharmaceutical products to market faster and develop workforce training programs for the biopharmaceutical field.

SOP Awarded Federal Contract to Study Abuse Deterrence of Opioid Drugs

November 6, 2013

Research seeks to improve formulation and manufacturing of opioid medications; deter individuals from abusing powerful pain relievers.

SOP’s Hoag Hosts New Tablets & Capsules Hands-On Short Course

October 30, 2013

In-depth lectures and practical laboratory exercises introduce participants to tablet and capsule manufacturing.

Grants Totaling a Potential $5M Awarded to SOP Researcher

October 10, 2013

Audra Stinchcomb, PhD, will use awards to advance transdermal and topical drug delivery research.

SOP Faculty Testify During FDA Generic Drug Regulation Public Meeting

July 3, 2013

Drs. Hoag and Polli examine current regulatory science initiatives aimed at generic drugs and discuss ways in which existing initiatives can be improved.

SOP Hosts World-Renowned Researchers During CERSI-Sponsored Conferences

June 4, 2013

New developments in pharmaceutical manufacturing and topical drug bioequivalence and bioavailability addressed in two day-long workshops.